IBDEI0HL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7877,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,7877,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,7878,0)
 ;;=L71.1^^55^531^135
 ;;^UTILITY(U,$J,358.3,7878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7878,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,7878,1,4,0)
 ;;=4^L71.1
 ;;^UTILITY(U,$J,358.3,7878,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,7879,0)
 ;;=L30.4^^55^531^36
 ;;^UTILITY(U,$J,358.3,7879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7879,1,3,0)
 ;;=3^Erythema intertrigo
 ;;^UTILITY(U,$J,358.3,7879,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,7879,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,7880,0)
 ;;=L26.^^55^531^39
 ;;^UTILITY(U,$J,358.3,7880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7880,1,3,0)
 ;;=3^Exfoliative dermatitis
 ;;^UTILITY(U,$J,358.3,7880,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,7880,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,7881,0)
 ;;=L53.8^^55^531^37
 ;;^UTILITY(U,$J,358.3,7881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7881,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,7881,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,7881,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,7882,0)
 ;;=L92.0^^55^531^47
 ;;^UTILITY(U,$J,358.3,7882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7882,1,3,0)
 ;;=3^Granuloma annulare
 ;;^UTILITY(U,$J,358.3,7882,1,4,0)
 ;;=4^L92.0
 ;;^UTILITY(U,$J,358.3,7882,2)
 ;;=^184052
 ;;^UTILITY(U,$J,358.3,7883,0)
 ;;=L95.1^^55^531^35
 ;;^UTILITY(U,$J,358.3,7883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7883,1,3,0)
 ;;=3^Erythema elevatum diutinum
 ;;^UTILITY(U,$J,358.3,7883,1,4,0)
 ;;=4^L95.1
 ;;^UTILITY(U,$J,358.3,7883,2)
 ;;=^5009477
 ;;^UTILITY(U,$J,358.3,7884,0)
 ;;=L98.2^^55^531^40
 ;;^UTILITY(U,$J,358.3,7884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7884,1,3,0)
 ;;=3^Febrile neutrophilic dermatosis [Sweet]
 ;;^UTILITY(U,$J,358.3,7884,1,4,0)
 ;;=4^L98.2
 ;;^UTILITY(U,$J,358.3,7884,2)
 ;;=^5009575
 ;;^UTILITY(U,$J,358.3,7885,0)
 ;;=L53.9^^55^531^38
 ;;^UTILITY(U,$J,358.3,7885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7885,1,3,0)
 ;;=3^Erythematous condition, unspecified
 ;;^UTILITY(U,$J,358.3,7885,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,7885,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,7886,0)
 ;;=L40.0^^55^531^131
 ;;^UTILITY(U,$J,358.3,7886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7886,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,7886,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,7886,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,7887,0)
 ;;=L40.8^^55^531^130
 ;;^UTILITY(U,$J,358.3,7887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7887,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,7887,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,7887,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,7888,0)
 ;;=L40.1^^55^531^46
 ;;^UTILITY(U,$J,358.3,7888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7888,1,3,0)
 ;;=3^Generalized pustular psoriasis
 ;;^UTILITY(U,$J,358.3,7888,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,7888,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,7889,0)
 ;;=L40.2^^55^531^2
 ;;^UTILITY(U,$J,358.3,7889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7889,1,3,0)
 ;;=3^Acrodermatitis continua
 ;;^UTILITY(U,$J,358.3,7889,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,7889,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,7890,0)
 ;;=L40.3^^55^531^132
 ;;^UTILITY(U,$J,358.3,7890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7890,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,7890,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,7890,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,7891,0)
 ;;=L40.4^^55^531^48
 ;;^UTILITY(U,$J,358.3,7891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7891,1,3,0)
 ;;=3^Guttate psoriasis
